Centrient Pharmaceuticals Initiates a Second Patent Litigation in India Against Dalas Biotech Limited

Centrient Pharmaceuticals (“Centrient”), the global leader in the production and commercialisation of sustainable, enzymatic antibiotics, next generation statins and anti-fungals, announced that it has filed a second lawsuit against Dalas Biotech Limited (“Dalas”) for patent infringement ROTTERDAM, The Netherlands, Oct. 18, 2019 (GLOBE NEWSWIRE) — Centrient Pharmaceuticals announced that on October 14th 2019, its wholly owned […]